Ragnar Danielsen1, Thor Aspelund2, Tamara B Harris3, Vilmundur Gudnason2. 1. The Department of Cardiology, Landspitali, University Hospital, Reykjavík, Iceland. Electronic address: ragnarda@landspitali.is. 2. The Icelandic Heart Association Research Institute, Kópavogur, Iceland; The University of Iceland, Reykjavík, Iceland. 3. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, MD, USA.
Abstract
AIMS: To evaluate the prevalence of significant aortic valve stenosis (AS) in a randomly selected study population of elderly individuals representing the general population of Iceland. Furthermore, to predict the number of individuals likely to have severe AS in the future. METHODS AND RESULTS:Echocardiography and computed tomography (CT) data from individuals who participated in the AGES-Reykjavik study were used. Echocardiography data from 685 individuals (58% females) aged 67-95 years were available. In both sexes combined, the prevalence for severe AS, defined as an aortic valve area index of <0.6 cm2/m2, in the age groups<70, 70-79 and ≥80 years was 0.92%, 2.4% and 7.3%, respectively. A ROC analysis on the relation between the echocardiography data and the aortic valve calcium score on CT defined a score≥500 to be indicative of severe AS. Subsequently, in a CT study cohort of 5256 individuals the prevalence of severe AS in the same age groups was 0.80%, 4.0% and 9.5%, respectively. Overall, the prevalence of severe AS by echocardiography and CT in individuals≥70 years was 4.3% and 5.9%, respectively. A prediction on the number of elderly≥70 years for the coming decades demonstrated that patients with severe AS will have increased 2.4 fold by the year 2040 and will more than triple by the year 2060. CONCLUSION: This study, in a cohort of elderly individuals representative of the general population in a Nordic country, predicts that AS will be a large health problem in the coming decades.
RCT Entities:
AIMS: To evaluate the prevalence of significant aortic valve stenosis (AS) in a randomly selected study population of elderly individuals representing the general population of Iceland. Furthermore, to predict the number of individuals likely to have severe AS in the future. METHODS AND RESULTS: Echocardiography and computed tomography (CT) data from individuals who participated in the AGES-Reykjavik study were used. Echocardiography data from 685 individuals (58% females) aged 67-95 years were available. In both sexes combined, the prevalence for severe AS, defined as an aortic valve area index of <0.6 cm2/m2, in the age groups<70, 70-79 and ≥80 years was 0.92%, 2.4% and 7.3%, respectively. A ROC analysis on the relation between the echocardiography data and the aortic valve calcium score on CT defined a score≥500 to be indicative of severe AS. Subsequently, in a CT study cohort of 5256 individuals the prevalence of severe AS in the same age groups was 0.80%, 4.0% and 9.5%, respectively. Overall, the prevalence of severe AS by echocardiography and CT in individuals≥70 years was 4.3% and 5.9%, respectively. A prediction on the number of elderly≥70 years for the coming decades demonstrated that patients with severe AS will have increased 2.4 fold by the year 2040 and will more than triple by the year 2060. CONCLUSION: This study, in a cohort of elderly individuals representative of the general population in a Nordic country, predicts that AS will be a large health problem in the coming decades.
Authors: Ronit Katz; Nathan D Wong; Richard Kronmal; Junichiro Takasu; David M Shavelle; Jeffrey L Probstfield; Alain G Bertoni; Matthew J Budoff; Kevin D O'Brien Journal: Circulation Date: 2006-04-24 Impact factor: 29.690
Authors: Ruben L J Osnabrugge; Darren Mylotte; Stuart J Head; Nicolas M Van Mieghem; Vuyisile T Nkomo; Corinne M LeReun; Ad J J C Bogers; Nicolo Piazza; A Pieter Kappetein Journal: J Am Coll Cardiol Date: 2013-05-30 Impact factor: 24.094
Authors: B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto Journal: J Am Coll Cardiol Date: 1997-03-01 Impact factor: 24.094
Authors: Bernard Iung; Agnès Cachier; Gabriel Baron; David Messika-Zeitoun; François Delahaye; Pilar Tornos; Christa Gohlke-Bärwolf; Eric Boersma; Philippe Ravaud; Alec Vahanian Journal: Eur Heart J Date: 2005-09-01 Impact factor: 29.983
Authors: Bernard Iung; Gabriel Baron; Eric G Butchart; François Delahaye; Christa Gohlke-Bärwolf; Olaf W Levang; Pilar Tornos; Jean-Louis Vanoverschelde; Frank Vermeer; Eric Boersma; Philippe Ravaud; Alec Vahanian Journal: Eur Heart J Date: 2003-07 Impact factor: 29.983
Authors: Ralf Koos; Andreas Horst Mahnken; Anil Martin Sinha; Joachim Ernst Wildberger; Rainer Hoffmann; Harald Peter Kühl Journal: AJR Am J Roentgenol Date: 2004-12 Impact factor: 3.959
Authors: Olga Vriz; Paolo Palatini; Lucio Mos; Hani AlSergani; Igor Vendramin; Ugolino Livi; Francesco Antonini-Canterin; Julien Magne Journal: Int J Cardiovasc Imaging Date: 2021-03-13 Impact factor: 2.357
Authors: Meghan A Bowler; Matthew R Bersi; Larisa M Ryzhova; Rachel J Jerrell; Aron Parekh; W David Merryman Journal: Am J Physiol Heart Circ Physiol Date: 2018-10-25 Impact factor: 4.733
Authors: Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot Journal: Nat Rev Dis Primers Date: 2016-03-03 Impact factor: 52.329
Authors: David S Owens; Traci M Bartz; Petra Buzkova; Daniele Massera; Mary L Biggs; Selma D Carlson; Bruce M Psaty; Nona Sotoodehnia; John S Gottdiener; Jorge R Kizer Journal: Heart Date: 2021-06-02 Impact factor: 7.365